US Stock MarketDetailed Quotes

MRUS Merus

Watchlist
  • 39.600
  • -2.490-5.92%
Close Apr 1 16:00 ET
  • 39.600
  • 0.0000.00%
Post 18:34 ET
2.74BMarket Cap-11.82P/E (TTM)

Merus Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
-17.78%36.13M
2.25%9.14M
6.70%11.77M
-30.01%7.33M
-41.56%7.89M
5.68%43.95M
-16.19%8.94M
67.65%11.03M
-17.41%10.48M
15.82%13.5M
Operating revenue
-17.78%36.13M
2.25%9.14M
6.70%11.77M
-30.01%7.33M
-41.56%7.89M
5.68%43.95M
-16.19%8.94M
67.65%11.03M
-17.41%10.48M
15.82%13.5M
Cost of revenue
Gross profit
Operating expense
53.72%308.2M
73.14%97.79M
70.05%84M
61.64%71.71M
8.85%54.7M
-0.56%200.49M
-12.20%56.48M
-9.81%49.4M
1.30%44.36M
29.75%50.25M
Selling and administrative expenses
38.43%82.83M
47.92%23.37M
64.92%20.77M
40.62%22.59M
4.73%16.11M
14.63%59.84M
3.36%15.8M
0.98%12.59M
26.53%16.06M
30.91%15.39M
-General and administrative expense
38.43%82.83M
47.92%23.37M
64.92%20.77M
40.62%22.59M
4.73%16.11M
14.63%59.84M
3.36%15.8M
0.98%12.59M
26.53%16.06M
30.91%15.39M
Research and development costs
60.22%225.37M
82.93%74.43M
71.80%63.24M
73.58%49.12M
10.67%38.58M
-5.87%140.66M
-17.05%40.69M
-12.99%36.81M
-9.00%28.3M
29.25%34.87M
Operating profit
-73.79%-272.07M
-86.47%-88.65M
-88.26%-72.23M
-89.98%-64.37M
-27.36%-46.81M
2.18%-156.55M
11.41%-47.54M
20.39%-38.37M
-8.93%-33.89M
-35.75%-36.75M
Net non-operating interest income expense
112.19%30.79M
63.29%8.49M
126.76%10.25M
155.10%7.13M
146.47%4.92M
433.06%14.51M
262.48%5.2M
422.17%4.52M
784.49%2.8M
1,782.08%2M
Non-operating interest income
----
----
126.76%10.25M
155.10%7.13M
----
----
----
--4.52M
784.49%2.8M
----
Total other finance cost
-112.19%-30.79M
----
----
----
-146.47%-4.92M
-433.06%-14.51M
----
----
----
-1,782.08%-2M
Other net income (expense)
451.22%34.1M
404.08%51M
-392.42%-34.95M
1,627.59%9.52M
256.85%8.53M
-135.86%-9.71M
42.87%-16.77M
-48.13%11.95M
-97.81%551K
-166.45%-5.44M
Gain on sale of security
451.22%34.1M
404.08%51M
-392.42%-34.95M
1,627.59%9.52M
256.85%8.53M
-137.31%-9.71M
42.87%-16.77M
-48.13%11.95M
-97.76%551K
-170.39%-5.44M
Income before tax
-36.53%-207.18M
50.67%-29.16M
-342.71%-96.93M
-56.28%-47.73M
17.02%-33.36M
-16.52%-151.75M
27.54%-59.12M
9.86%-21.89M
-447.00%-30.54M
-114.06%-40.2M
Income tax
155.36%8.15M
69.62%1.76M
166.28%2.98M
55.09%2.32M
340.26%1.1M
232.85%3.19M
167.96%1.04M
241.90%1.12M
1,040.46%1.49M
-500.88%-457K
Net income
-38.97%-215.33M
48.59%-30.92M
-334.14%-99.91M
-56.22%-50.04M
13.30%-34.46M
-18.10%-154.94M
26.62%-60.15M
6.51%-23.01M
-460.61%-32.03M
-110.35%-39.74M
Net income continuous Operations
-38.97%-215.33M
48.59%-30.92M
-334.14%-99.91M
-56.22%-50.04M
13.30%-34.46M
-18.10%-154.94M
26.62%-60.15M
6.51%-23.01M
-460.61%-32.03M
-110.35%-39.74M
Minority interest income
Net income attributable to the parent company
-38.97%-215.33M
48.59%-30.92M
-334.14%-99.91M
-56.22%-50.04M
13.30%-34.46M
-18.10%-154.94M
26.62%-60.15M
6.51%-23.01M
-460.61%-32.03M
-110.35%-39.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-38.97%-215.33M
48.59%-30.92M
-334.14%-99.91M
-56.22%-50.04M
13.30%-34.46M
-18.10%-154.94M
26.62%-60.15M
6.51%-23.01M
-460.61%-32.03M
-110.35%-39.74M
Basic earnings per share
-11.67%-3.35
62.39%-0.41
-239.53%-1.46
-22.73%-0.81
31.40%-0.59
-2.74%-3
39.78%-1.09
18.87%-0.43
-407.69%-0.66
-100.00%-0.86
Diluted earnings per share
-11.67%-3.35
62.39%-0.41
-239.53%-1.46
-22.73%-0.81
31.40%-0.59
-2.74%-3
39.78%-1.09
18.87%-0.43
-407.69%-0.66
-100.00%-0.86
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue -17.78%36.13M2.25%9.14M6.70%11.77M-30.01%7.33M-41.56%7.89M5.68%43.95M-16.19%8.94M67.65%11.03M-17.41%10.48M15.82%13.5M
Operating revenue -17.78%36.13M2.25%9.14M6.70%11.77M-30.01%7.33M-41.56%7.89M5.68%43.95M-16.19%8.94M67.65%11.03M-17.41%10.48M15.82%13.5M
Cost of revenue
Gross profit
Operating expense 53.72%308.2M73.14%97.79M70.05%84M61.64%71.71M8.85%54.7M-0.56%200.49M-12.20%56.48M-9.81%49.4M1.30%44.36M29.75%50.25M
Selling and administrative expenses 38.43%82.83M47.92%23.37M64.92%20.77M40.62%22.59M4.73%16.11M14.63%59.84M3.36%15.8M0.98%12.59M26.53%16.06M30.91%15.39M
-General and administrative expense 38.43%82.83M47.92%23.37M64.92%20.77M40.62%22.59M4.73%16.11M14.63%59.84M3.36%15.8M0.98%12.59M26.53%16.06M30.91%15.39M
Research and development costs 60.22%225.37M82.93%74.43M71.80%63.24M73.58%49.12M10.67%38.58M-5.87%140.66M-17.05%40.69M-12.99%36.81M-9.00%28.3M29.25%34.87M
Operating profit -73.79%-272.07M-86.47%-88.65M-88.26%-72.23M-89.98%-64.37M-27.36%-46.81M2.18%-156.55M11.41%-47.54M20.39%-38.37M-8.93%-33.89M-35.75%-36.75M
Net non-operating interest income expense 112.19%30.79M63.29%8.49M126.76%10.25M155.10%7.13M146.47%4.92M433.06%14.51M262.48%5.2M422.17%4.52M784.49%2.8M1,782.08%2M
Non-operating interest income --------126.76%10.25M155.10%7.13M--------------4.52M784.49%2.8M----
Total other finance cost -112.19%-30.79M-------------146.47%-4.92M-433.06%-14.51M-------------1,782.08%-2M
Other net income (expense) 451.22%34.1M404.08%51M-392.42%-34.95M1,627.59%9.52M256.85%8.53M-135.86%-9.71M42.87%-16.77M-48.13%11.95M-97.81%551K-166.45%-5.44M
Gain on sale of security 451.22%34.1M404.08%51M-392.42%-34.95M1,627.59%9.52M256.85%8.53M-137.31%-9.71M42.87%-16.77M-48.13%11.95M-97.76%551K-170.39%-5.44M
Income before tax -36.53%-207.18M50.67%-29.16M-342.71%-96.93M-56.28%-47.73M17.02%-33.36M-16.52%-151.75M27.54%-59.12M9.86%-21.89M-447.00%-30.54M-114.06%-40.2M
Income tax 155.36%8.15M69.62%1.76M166.28%2.98M55.09%2.32M340.26%1.1M232.85%3.19M167.96%1.04M241.90%1.12M1,040.46%1.49M-500.88%-457K
Net income -38.97%-215.33M48.59%-30.92M-334.14%-99.91M-56.22%-50.04M13.30%-34.46M-18.10%-154.94M26.62%-60.15M6.51%-23.01M-460.61%-32.03M-110.35%-39.74M
Net income continuous Operations -38.97%-215.33M48.59%-30.92M-334.14%-99.91M-56.22%-50.04M13.30%-34.46M-18.10%-154.94M26.62%-60.15M6.51%-23.01M-460.61%-32.03M-110.35%-39.74M
Minority interest income
Net income attributable to the parent company -38.97%-215.33M48.59%-30.92M-334.14%-99.91M-56.22%-50.04M13.30%-34.46M-18.10%-154.94M26.62%-60.15M6.51%-23.01M-460.61%-32.03M-110.35%-39.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -38.97%-215.33M48.59%-30.92M-334.14%-99.91M-56.22%-50.04M13.30%-34.46M-18.10%-154.94M26.62%-60.15M6.51%-23.01M-460.61%-32.03M-110.35%-39.74M
Basic earnings per share -11.67%-3.3562.39%-0.41-239.53%-1.46-22.73%-0.8131.40%-0.59-2.74%-339.78%-1.0918.87%-0.43-407.69%-0.66-100.00%-0.86
Diluted earnings per share -11.67%-3.3562.39%-0.41-239.53%-1.46-22.73%-0.8131.40%-0.59-2.74%-339.78%-1.0918.87%-0.43-407.69%-0.66-100.00%-0.86
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
OKAY
833230
+29.96%
CHANGFU CO.,LTD
871396
+24.59%
Gansu Longshenrongfa Pharmaceutical Industry
300534
+20.05%
4
Tibet Duo Rui Pharmaceutical
301075
+20.02%
5
Chengda Pharmaceuticals
301201
+20.01%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.